Global Perioral Dermatitis Treatment Market Is Predicted to Grow Around USD 112 Million By 2030

The global perioral dermatitis treatment market size was worth around USD 67 Million in 2022 and is predicted to grow to around USD 112 Million by 2030 with a compound annual growth rate (CAGR) of roughly 6.71% between 2023 and 2030.

The perioral dermatitis treatment industry deals with the production and distribution of medicines or treatments that are designed to address perioral dermatitis, a common skin condition characterized by a red, bumpy rash around the mouth area. Perioral dermatitis primarily affects women between the ages of 16 and 45, although it can also occur in men and children.

The market deals with treatments that assist in alleviating the symptoms or managing the condition. In recent times, the industry has witnessed significant growth and during the forecast period, it is expected to continue the same trend. However, there are certain limitations that prohibit the market from attaining its true potential.

The global perioral dermatitis treatment market is projected to grow owing to the increasing awareness of the condition and treatments available in the healthcare market. There are several factors that drive the awareness rate such as initiatives undertaken by healthcare units and government entities. With growing access to information on the internet and easier information accessibility, more people are undertaking proactive measures by undertaking medical advice to curb the symptoms and explore available treatment options.

Furthermore, the development of advanced treatment options, including topical medications, oral antibiotics, and other therapeutic interventions, has expanded the range of choices for managing perioral dermatitis. Factors such as improved drug delivery systems and targeted therapies contribute to more effective treatment approaches. These factors have resulted in an increased emphasis on research & development for better therapies which further fuels the market growth. Other factors such as increased healthcare expenditure and technological advancements in skin care are equally responsible for higher growth.

One of the key restraints existing in the perioral dermatitis treatment industry  is the significant lack of understanding of the main reasons for the onset of the condition. Moreover, it sometimes tends to recur with periods of remission and flare-ups, even after prolonged treatment. In certain cases, perioral dermatitis has become chronic which effectively diminishes the quality of life. The recurrence and chronic nature of perioral dermatitis can be frustrating for patients. In addition to this, some treatment options for perioral dermatitis, such as topical corticosteroids and oral antibiotics, can have potential side effects and limitations.

The increasing investment toward targeted therapies could provide growth opportunities while the lack of standard treatment protocol may create challenges.

The global perioral dermatitis treatment market is segmented based on diagnosis, treatment, end-user, and region.

Based on diagnosis, the global market segments are skin biopsy, physical examination, and others. The industry witnessed the highest growth in the physical examination segment since perioral dermatitis is most effectively diagnosed when the dermatologist and the patient can come face to face.

The detection of characteristic appearance and distribution of the rash around along with an absence of the vermillion border is most likely to be effectively concluded in physical examination. However, certain cases may need more assistance and in such situations, a skin biopsy can be used along with a physical examination. A skin biopsy can help differentiate perioral dermatitis from other skin conditions that have similar conditions. As per the American Academy of Dermatology, there are 24 skin disease categories in recent times.

Based on treatment, the global market segments are antibiotics, topical ivermectin, immunosuppressive agents, and others. The perioral dermatitis treatment industry was led by the topical ivermectin segment since generally doctors recommend topical medicines and change in lifestyle. Topical antibiotics such as metronidazole or erythromycin, are commonly prescribed as first-line treatment options. Furthermore, incorporating certain lifestyle changes such as avoiding the use of harsh chemicals or adopting gentle skincare regimens can also assist in managing the symptoms. However, the treatment method depends on the patient and the intensity of the condition. More than 90% of the cases are seen in young women.

Based on end-user, the global market segments are homecare, specialty clinics, hospitals, and others.

North America is expected to have a significant share in the global perioral dermatitis treatment market due to advanced healthcare infrastructure, high awareness about skin conditions, and availability of a wide range of treatment options. The availability of advanced treatment options and increasing awareness among healthcare professionals and patients drive market growth in North America.

Europe is likely to be another prominent market for perioral dermatitis treatment. The region has a well-established healthcare system, a high prevalence of skin disorders, and a strong emphasis on dermatological care.

The Asia Pacific region is expected to witness significant growth in the perioral dermatitis treatment market. Factors such as a large population base, increasing disposable income, improving healthcare infrastructure, and rising awareness about skin conditions contribute to the market expansion. The market growth in countries like China, India, and Japan is particularly noteworthy.

Browse the full “Perioral Dermatitis Treatment Market By Diagnosis (Skin Biopsy, Physical Examination, and Others), By Treatment (Antibiotics, Topical Ivermectin, Immunosuppressive Agents, and Others), By End-User (Homecare, Specialty Clinics, Hospitals, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030.” Report at https://www.zionmarketresearch.com/report/perioral-dermatitis-treatment-market

Recent Developments:

• In November 2020, a medical report posted on Medscape with the headline “Perioral Dermatitis Medication’ pointed out that topical calcineurin inhibitors are effective in treating pediatric patients of the disease
• In February 2022, Dadu Medical Center announced the launch of a new state-of-the-art skincare facility in Delhi, India

The global perioral dermatitis treatment market is led by players like

• Pfizer Inc.
• Novartis International AG
• Johnson & Johnson
• Roche Holding AG
• Merck & Co. Inc.
• GlaxoSmithKline plc
• AstraZeneca plc
• Sanofi SA
• AbbVie Inc.
• Gilead Sciences Inc.
• Bristol Myers Squibb Company
• Eli Lilly and Company
• Novo Nordisk A/S
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Takeda Pharmaceutical Company Limited
• Moderna Inc.
• Vertex Pharmaceuticals Incorporated
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Celgene Corporation
• Astellas Pharma Inc.
• and Alexion Pharmaceuticals Inc.

The global perioral dermatitis treatment market is segmented as follows:

By Diagnosis

• Skin Biopsy
• Physical Examination
• Others

By Treatment

• Antibiotics
• Topical Ivermectin
• Immunosuppressive Agents
• Others

By End-User

• Homecare
• Specialty Clinics
• Hospitals
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com